Deborah Cooper

A securities lawsuit alleges Graphic Packaging hid major problems from its investors. It’s a case study in how corporate transparency can make or break public trust.

In classified operations, a chatroom's member list is a security control. A new partnership finally treats it that way, closing a critical Zero Trust gap.

A landmark publication in The Lancet unveils AC01, a novel oral drug that safely improves heart function, offering a beacon of hope for millions with heart failure.

Oblenio Bio's oversubscribed Series B will advance a novel tri-specific T-cell engager, aiming to reset the immune system without harsh side effects.

The Monterey Motorsports Festival is trading tradition for TikTok fame, betting on viral DJs and social media stars to attract a new generation to the classic car world.

In Qinghai, new price indices for yak and Tibetan sheep aim to digitize a traditional way of life, empowering herders against global markets. But can data truly capture value?

Researchers have developed a nanoparticle that mimics diseased cells, allowing for rapid screening of cancer targets. It's a key step toward truly personal vaccines.

A new federal investment targets the growing health crisis of climate change, funding projects from system-wide resilience to protecting our most vulnerable.

A massive shareholder lock-up at One and One Green Technologies signals deep confidence. But is it just a stock play, or a sign of a deeper revolution in sustainable industry?

A new survey shows advisors face a fundamental reset. They must balance AI's threat and promise, capture a historic $84T wealth transfer, and guide clients through volatility.

A landmark deal brings VIZZ, a once-daily presbyopia treatment, to Australia and New Zealand, promising millions a life with less reliance on reading glasses.

Heparin, a trusted blood thinner, can trigger a fatal immune reaction. A small biotech's novel drug is now taking the global stage with a targeted solution.

Beneath the buzz of flying cars and humanoid robots lies a world of coils and magnets. A major Shanghai expo reveals the physical heart of our digital future.

Fresh off its IPO, EagleRock Land wipes its debt slate clean. How this strategic reset positions the company to dominate the future of energy and infrastructure.

A new law makes Illinois a pioneer, mandating Medicaid coverage for predictive blood tests. Can this tech-driven policy shift the tide on maternal health?

A new wave of federal grants is expanding a national network of specialized hospitals. It’s a proactive strategy to ensure we're ready for the next pandemic.

As Vancouver braces for a World Cup accommodation crisis, sophisticated rental scams are surging. A new tech tool aims to fight back by verifying listings.

Unsanctioned apps and AI tools create a shadow ecosystem of risk and cost. A new class of platforms aims to restore order, but can they build trust?

DaysToHappy's new HealthScan promises to read your vitals from a selfie. We analyze the tech, the market, and the critical privacy questions.

As the carbon market struggles with a trust deficit, Gevo bets on a new digital platform and verifiable delivery to turn promises into a bankable climate solution.